Matches in Wikidata for { <http://www.wikidata.org/entity/Q61837654> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q61837654 description "artículu científicu espublizáu en marzu de 2018" @default.
- Q61837654 description "im Mai 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q61837654 description "scientific article published on 26 March 2018" @default.
- Q61837654 description "wetenschappelijk artikel" @default.
- Q61837654 description "наукова стаття, опублікована в травні 2018" @default.
- Q61837654 name "Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency - The leading cause of preeclampsia" @default.
- Q61837654 name "Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency - The leading cause of preeclampsia" @default.
- Q61837654 type Item @default.
- Q61837654 label "Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency - The leading cause of preeclampsia" @default.
- Q61837654 label "Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency - The leading cause of preeclampsia" @default.
- Q61837654 prefLabel "Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency - The leading cause of preeclampsia" @default.
- Q61837654 prefLabel "Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency - The leading cause of preeclampsia" @default.
- Q61837654 P1433 Q61837654-529FDF30-6DD0-41F3-883D-165AE1A8D082 @default.
- Q61837654 P1476 Q61837654-ED70AEBD-4256-4FD8-AAD6-FD9D722C28D8 @default.
- Q61837654 P2093 Q61837654-0F2E1E10-4D65-4F4F-A722-F903A6D07A2C @default.
- Q61837654 P2093 Q61837654-1CCEABE7-51A6-4C9E-8E4F-1BC57B59CD7A @default.
- Q61837654 P2093 Q61837654-20A77A62-F4CB-4A95-B33A-CB05060A503D @default.
- Q61837654 P2093 Q61837654-313D2F59-9860-41B7-A177-ADF3BDB2CD1C @default.
- Q61837654 P2093 Q61837654-451D0A7C-F844-47A5-9896-E3ABABCF2369 @default.
- Q61837654 P2093 Q61837654-6B5B46B9-9EBB-40AB-BE64-35F0BDBED996 @default.
- Q61837654 P2093 Q61837654-873D5CD7-4692-4CDE-A1B7-C299BE74EA64 @default.
- Q61837654 P2093 Q61837654-AB22DB90-1109-45DA-8E04-3ACBCB3E4E39 @default.
- Q61837654 P2093 Q61837654-F84137B1-EC63-4E5A-8DDA-61C6848ACFD4 @default.
- Q61837654 P304 Q61837654-650812DD-C3AD-4EF4-84CE-6D69EEC74589 @default.
- Q61837654 P31 Q61837654-F25C8B07-6AE3-4A81-A524-8163A6ADD54F @default.
- Q61837654 P356 Q61837654-4B1CC111-A646-4983-86FB-CFDDA062A53E @default.
- Q61837654 P407 Q61837654-20AF198B-0E5E-464A-92FB-D3F0C3648F4B @default.
- Q61837654 P478 Q61837654-F3B2FB0E-2BBC-423F-869F-6EE324D616FB @default.
- Q61837654 P577 Q61837654-EE047912-E344-4F0B-AA37-46AF3426CC95 @default.
- Q61837654 P698 Q61837654-82C83EAF-F93C-4A7D-A5DF-945470181E4F @default.
- Q61837654 P921 Q61837654-13FC7FEF-BB13-4851-9788-5E0E4B67F27E @default.
- Q61837654 P921 Q61837654-69883490-59D5-4318-A4E4-903933324292 @default.
- Q61837654 P921 Q61837654-8278670C-299B-4583-AE52-A74321ED7A99 @default.
- Q61837654 P921 Q61837654-959A09C9-55DF-4418-A413-839C6208755A @default.
- Q61837654 P921 Q61837654-AC7F5109-FCF3-49D2-85A5-961FAA70C215 @default.
- Q61837654 P921 Q61837654-BE758798-FE9C-4DE2-B542-032A9AA30245 @default.
- Q61837654 P921 Q61837654-D0F50920-7EFF-4D97-B4B5-FBFC5F1D6167 @default.
- Q61837654 P356 J.PLACENTA.2018.03.006 @default.
- Q61837654 P698 29908636 @default.
- Q61837654 P1433 Q7200288 @default.
- Q61837654 P1476 "Recombinant human soluble thrombomodulin as an anticoagulation therapy improves recurrent miscarriage and fetal growth restriction due to placental insufficiency - The leading cause of preeclampsia" @default.
- Q61837654 P2093 "Atsuko Okamoto" @default.
- Q61837654 P2093 "Atsushi Daimon" @default.
- Q61837654 P2093 "Daisuke Fujita" @default.
- Q61837654 P2093 "Masahide Ohmichi" @default.
- Q61837654 P2093 "Masami Hayashi" @default.
- Q61837654 P2093 "Misa Nunode" @default.
- Q61837654 P2093 "Takumi Sano" @default.
- Q61837654 P2093 "Yoko Nagayasu" @default.
- Q61837654 P2093 "Yoshito Terai" @default.
- Q61837654 P304 "1-6" @default.
- Q61837654 P31 Q13442814 @default.
- Q61837654 P356 "10.1016/J.PLACENTA.2018.03.006" @default.
- Q61837654 P407 Q1860 @default.
- Q61837654 P478 "65" @default.
- Q61837654 P577 "2018-03-26T00:00:00Z" @default.
- Q61837654 P698 "29908636" @default.
- Q61837654 P921 Q1671598 @default.
- Q61837654 P921 Q2099138 @default.
- Q61837654 P921 Q25787 @default.
- Q61837654 P921 Q28306483 @default.
- Q61837654 P921 Q50271605 @default.
- Q61837654 P921 Q61335 @default.
- Q61837654 P921 Q63279445 @default.